Literature DB >> 29874185

Coagulation Factors in Ischemic Heart Disease: Answers From a Mendelian Randomization Study Inspire Further Questions.

Stella Aslibekyan1, Patrick R Lawler2.   

Abstract

Entities:  

Keywords:  Editorials; bias; genotype; lipids; myocardial infarction; thrombin

Mesh：

Substances：

Year:  2018        PMID： 29874185      PMCID： PMC5992499          DOI： 10.1161/CIRCGEN.117.002045

Source DB:  PubMed          Journal:  Circ Genom Precis Med        ISSN： 2574-8300


× No keyword cloud information.
  9 in total

Review 1.  Methodological challenges in mendelian randomization.

Authors:  Tyler J VanderWeele; Eric J Tchetgen Tchetgen; Marilyn Cornelis; Peter Kraft
Journal:  Epidemiology       Date:  2014-05       Impact factor: 4.822

2.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Authors:  John W Eikelboom; Stuart J Connolly; Jackie Bosch; Gilles R Dagenais; Robert G Hart; Olga Shestakovska; Rafael Diaz; Marco Alings; Eva M Lonn; Sonia S Anand; Petr Widimsky; Masatsugu Hori; Alvaro Avezum; Leopoldo S Piegas; Kelley R H Branch; Jeffrey Probstfield; Deepak L Bhatt; Jun Zhu; Yan Liang; Aldo P Maggioni; Patricio Lopez-Jaramillo; Martin O'Donnell; Ajay K Kakkar; Keith A A Fox; Alexander N Parkhomenko; Georg Ertl; Stefan Störk; Matyas Keltai; Lars Ryden; Nana Pogosova; Antonio L Dans; Fernando Lanas; Patrick J Commerford; Christian Torp-Pedersen; Tomek J Guzik; Peter B Verhamme; Dragos Vinereanu; Jae-Hyung Kim; Andrew M Tonkin; Basil S Lewis; Camilo Felix; Khalid Yusoff; P Gabriel Steg; Kaj P Metsarinne; Nancy Cook Bruns; Frank Misselwitz; Edmond Chen; Darryl Leong; Salim Yusuf
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

3.  Apolipoprotein E isoforms, serum cholesterol, and cancer.

Authors:  M B Katan
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

4.  Coagulation Factors and the Risk of Ischemic Heart Disease: A Mendelian Randomization Study.

Authors:  Jie V Zhao; C Mary Schooling
Journal:  Circ Genom Precis Med       Date:  2018-01-12

5.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

6.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.

Authors:  Jack Bowden; George Davey Smith; Stephen Burgess
Journal:  Int J Epidemiol       Date:  2015-06-06       Impact factor: 7.196

Review 7.  ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis.

Authors:  Zhuo Chen; Sheng-Hua Yang; Hao Xu; Jian-Jun Li
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

8.  Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects.

Authors:  Jaewoo Song; Fengju Chen; Marco Campos; Doug Bolgiano; Katie Houck; Lloyd E Chambless; Kenneth K Wu; Aaron R Folsom; David Couper; Eric Boerwinkle; Jing-fei Dong
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

9.  Use of allele scores as instrumental variables for Mendelian randomization.

Authors:  Stephen Burgess; Simon G Thompson
Journal:  Int J Epidemiol       Date:  2013-08       Impact factor: 7.196
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.